Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice

Christiansen, S N, Horskjær Rasmussen, S, Pons, M, Michelsen, B, Glintborg, B, Gudbjornsson, B, Grondal, G, Vencovsky, J, Loft, A G, Rotar, Z, Pirkmajer, K P, Nissen, M J, Baranová, J, Macfarlane, G J, Jones, G T, Iannone, F, Caporali, R, Laas, K, Vorobjov, S, Giuseppe, D D, Olofsson, T, Provan, S A, Fagerli, K M, Castrejon, I, Otero-Varela, L, van de Sande, M, van der Horst-Bruinsma, I, Nordström, D, Kuusalo, L, Bernardes, M, Hetland, M L, Østergaard, M & Midtbøll Ørnbjerg, L 2024, 'Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice', Seminars in arthritis and rheumatism, vol. 65, 152388. https://doi.org/10.1016/j.semarthrit.2024.152388